Emaretamig is a humanized IgG1κ monoclonal antibody inhibitor that targets CLDN18 and CD3E. Abdakibart is applicable for cancer research related to gastric and pancreatic cancers.
Emaretamig
Copy Product Info
🥰Excellent
Catalog No. T9901A-1873
Emaretamig is a humanized IgG1κ monoclonal antibody inhibitor that targets CLDN18 and CD3E. Abdakibart is applicable for cancer research related to gastric and pancreatic cancers.
Emaretamig
Cas No. 3051701-97-1
Pack Size
Price
USA Stock
Global Stock
Quantity
1 mg
Inquiry
Inquiry
Inquiry
5 mg
Inquiry
Inquiry
Inquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Emaretamig is a humanized IgG1κ monoclonal antibody inhibitor that targets CLDN18 and CD3E. Abdakibart is applicable for cancer research related to gastric and pancreatic cancers.
Chemical Properties
Cas No.
3051701-97-1
Storage & Solubility Information
Storage
store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.
Calculator
Dilution Calculator
Reconstitution Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Emaretamig | purchase Emaretamig | Emaretamig cost | order Emaretamig